AbbVie Inc.
ABBV
$225.11
-$2.59-1.14%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 59.64B | 58.33B | 57.37B | 56.33B | 55.53B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 59.64B | 58.33B | 57.37B | 56.33B | 55.53B |
| Cost of Revenue | 17.20B | 16.95B | 16.81B | 16.87B | 16.65B |
| Gross Profit | 42.44B | 41.38B | 40.56B | 39.47B | 38.88B |
| SG&A Expenses | 12.70B | 13.32B | 13.45B | 13.29B | 13.97B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -31.00M | -31.00M | -7.00M | -7.00M | 169.00M |
| Total Operating Expenses | 38.66B | 38.81B | 38.63B | 38.28B | 38.55B |
| Operating Income | 20.98B | 19.52B | 18.73B | 18.05B | 16.99B |
| Income Before Tax | 1.66B | 3.03B | 3.62B | 3.72B | 7.20B |
| Income Tax Expenses | -735.00M | -741.00M | -581.00M | -570.00M | 2.06B |
| Earnings from Continuing Operations | 2.40K | 3.77K | 4.20K | 4.29K | 5.13K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -7.00M | -8.00M | -8.00M | -8.00M | -11.00M |
| Net Income | 2.39B | 3.76B | 4.20B | 4.28B | 5.12B |
| EBIT | 20.98B | 19.52B | 18.73B | 18.05B | 16.99B |
| EBITDA | 29.24B | 27.79B | 27.08B | 26.44B | 25.35B |
| EPS Basic | 1.33 | 2.11 | 2.35 | 2.40 | 2.87 |
| Normalized Basic EPS | 6.60 | 6.11 | 5.90 | 5.72 | 5.42 |
| EPS Diluted | 1.32 | 2.10 | 2.35 | 2.40 | 2.87 |
| Normalized Diluted EPS | 6.59 | 6.10 | 5.89 | 5.72 | 5.41 |
| Average Basic Shares Outstanding | 7.07B | 7.07B | 7.07B | 7.08B | 7.08B |
| Average Diluted Shares Outstanding | 7.08B | 7.08B | 7.08B | 7.09B | 7.09B |
| Dividend Per Share | 6.56 | 6.47 | 6.38 | 6.29 | 6.20 |
| Payout Ratio | 481.49% | 301.30% | 266.46% | 257.71% | 212.79% |